Total Funding
36
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
84598
ALung Technologies develops medical gas exchange devices for the treatment of acute and chronic respiratory disorders.
Peter M. DeComo: Chairman and CEO
David Haffner: EVP , Chief Operating Officer & Chief Financial Officer
About the Company
ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed
within the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein.
The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania.
